1 | Health | 5.56% | |
2 | Impact | 5.56% | |
3 | Diagnostics | 1.85% | |
4 | (Alliance | 1.85% | |
5 | EXPERT | 1.85% | |
6 | Bat | 1.85% | |
7 | (PREDICT) | 1.85% | |
8 | Boost | 1.85% | |
9 | Medicines | 1.85% | |
10 | Study | 1.85% | |
11 | Respiratory | 1.85% | |
12 | Laos | 1.85% | |
13 | Oral | 1.85% | |
14 | Could | 1.85% | |
15 | Motor | 1.85% | |
16 | Chinas | 1.85% | |
17 | Womens | 1.85% | |
18 | Sexual | 1.85% | |
19 | Particulate | 1.85% | |
20 | Patients | 1.85% | |
21 | Colorectal | 1.85% | |
22 | Wegovy | 1.85% | |
23 | Multi-Arm | 1.85% | |
24 | Ozempic | 1.85% | |
25 | LD-Writethru | 1.85% | |
26 | Biomarker-Based | 1.85% | |
27 | HPV | 1.85% | |
28 | Jump | 1.85% | |
29 | Treatment | 1.85% | |
30 | Matter | 1.85% | |
31 | Cancers | 1.85% | |
32 | AI | 1.85% | |
33 | Guidance | 1.85% | |
34 | REACTION | 1.85% | |
35 | UK | 1.85% | |
36 | Anorexia | 1.85% | |
37 | Cancer | 1.85% | |
38 | Humans | 1.85% | |
39 | Prostate | 1.85% | |
40 | MERS | 1.85% | |
41 | Breakthrough | 1.85% | |
42 | ASCO | 1.85% | |
43 | A032102) | 1.85% | |
44 | Phage | 1.85% | |
45 | Viruses | 1.85% | |
46 | Trials-in-Progress | 1.85% | |
47 | We’re | 1.85% | |
48 | Precision | 1.85% | |
49 | Covid | 1.85% | |
50 | Phase | 1.85% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|